PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.07
Similar ESG score to ANVS's 61.77. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
54.47
Environmental score 1.1-1.2x ANVS's 51.78. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
61.36
Similar social score to ANVS's 61.30. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
61.37
Governance score 80-90% of ANVS's 72.22. Walter Schloss would scrutinize management accountability and board independence.